HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical study on sparfloxacin (SPFX) in the treatment of mycoplasmal pneumonia and penetration of SPFX to the pneumonic lesion].

Abstract
We treated nine patients of mycoplasmal pneumonia with sparfloxacin (SPFX) the clinical efficacy, safety and usefulness of SPFX were evaluated. SPFX was administered orally at doses of 200 or 300 mg once daily, and we performed bronchoalveolar lavage (BAL) examinations in five patients. BAL was performed 5 hours after oral administration of 100 mg in one case, 19 hours after oral administration of 200 mg in four cases. Concentrations of SPFX and alubumine were measured in serum and in BALF (bronchoalveolar lavage fluid). The following results were obtained. 1. Nine patients were evaluated; eight patients judged as Good, one patient as Excellent. 2. The serum and BALF levels of SPFX was 0.79 microgram/ml, 0.107 microgram/ml 5 hours after single oral administration of 100 mg in one case and 19 hours after oral administration of 200 mg in four cases, those of levels of SPFX were 0.835 +/- 0.274 microgram/ml and 0.081 +/- 0.033 microgram/ml, respectively. 3. The ratio of SPFX/albumin in BALF was significantly higher than in the serum. From these results, we consider that SPFX is a useful antimicrobial agent for mycoplasmal pneumonia.
AuthorsY Hayashi, G Ito, S Takeyama
JournalKansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases (Kansenshogaku Zasshi) Vol. 72 Issue 1 Pg. 54-9 (Jan 1998) ISSN: 0387-5911 [Print] Japan
PMID9503785 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Anti-Infective Agents
  • Fluoroquinolones
  • Quinolones
  • sparfloxacin
Topics
  • Administration, Oral
  • Adolescent
  • Adult
  • Anti-Infective Agents (administration & dosage, therapeutic use)
  • Bacterial Translocation
  • Bronchoalveolar Lavage Fluid (microbiology)
  • Female
  • Fluoroquinolones
  • Humans
  • Male
  • Middle Aged
  • Mycoplasma (physiology)
  • Pneumonia, Mycoplasma (drug therapy, microbiology)
  • Quinolones (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: